Brought to you by 
Outpost Medicine raises $41mm through Series A round; adds $20mm
16 Nov 2017
Executive Summary
Outpost Medicine, a new biopharma company launched by Frazier Healthcare Partners and Takeda Pharmaceutical Co. Ltd., raised $41mm through its Series A round. Frazier led the fundraise, and was joined by Adams Street Partners, Novo AS, and Vivo Partners. All of the investors get board seats.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Outpost Medicine raises $41mm through Series A round; adds $20mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice